These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10276247)

  • 1. Strategies for technology assessment and implementation in some European countries.
    Stocking B
    Int J Technol Assess Health Care; 1986; 2(1):19-26. PubMed ID: 10276247
    [No Abstract]   [Full Text] [Related]  

  • 2. Health care technology as a policy issue.
    Banta HD
    Health Policy; 1994; 30(1-3):1-21. PubMed ID: 10139487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from the eight countries.
    Battista RN; Banta HD; Jonnson E; Hodge M; Gelband H
    Health Policy; 1994; 30(1-3):397-421. PubMed ID: 10139496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of health technology assessment in Europe. A personal perspective.
    Jonsson E
    Int J Technol Assess Health Care; 2002; 18(2):171-83. PubMed ID: 12053417
    [No Abstract]   [Full Text] [Related]  

  • 5. A national policy for health care technology assessment.
    Perry S; Pillar B
    Med Care Rev; 1990; 47(4):401-17. PubMed ID: 10113012
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical industry's perspective on health technology assessment.
    Lothgren M; Ratcliffe M
    Int J Technol Assess Health Care; 2004; 20(1):97-101. PubMed ID: 15176185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential impact of improvements in contraception on fertility and abortion in Western countries.
    Westoff CF; Hammerslough CR; Paul L
    Eur J Popul; 1987 Nov; 3(1):7-32. PubMed ID: 12280731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Medicines Agency is attacked over proposal to allow technology assessment bodies to sell advice to drug industry.
    Wise J
    BMJ; 2014 Jul; 349():g4674. PubMed ID: 25033980
    [No Abstract]   [Full Text] [Related]  

  • 9. Methods, procedures, and contextual characteristics of health technology assessment and health policy decision making: comparison of health technology assessment agencies in Germany, United Kingdom, France, and Sweden.
    Schwarzer R; Siebert U
    Int J Technol Assess Health Care; 2009 Jul; 25(3):305-14. PubMed ID: 19619349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reflections on the evolution of health technology assessment in Europe.
    Sorenson C; Chalkidou K
    Health Econ Policy Law; 2012 Jan; 7(1):25-45. PubMed ID: 22221927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO review committee makes NICE recommendations.
    McLellan F
    Lancet; 2003 Sep; 362(9388):966. PubMed ID: 14513843
    [No Abstract]   [Full Text] [Related]  

  • 12. NICE: mostly a bad idea.
    Leaman A
    Emerg Med J; 2009 Sep; 26(9):627-8. PubMed ID: 19700572
    [No Abstract]   [Full Text] [Related]  

  • 13. Research funding: the problem with priorities.
    Nat Mater; 2003 Oct; 2(10):639. PubMed ID: 14520338
    [No Abstract]   [Full Text] [Related]  

  • 14. NICE appraisals should be everybody's business.
    Wells J; Cheong-Leen C
    BMJ; 2007 May; 334(7600):936-8. PubMed ID: 17478847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies in technology assessment and implementation in the United States.
    Young DA
    Int J Technol Assess Health Care; 1986; 2(1):13-8. PubMed ID: 10300717
    [No Abstract]   [Full Text] [Related]  

  • 16. Research and commerce.
    Ferguson MJ
    Lancet; 1994 Nov; 344(8934):1436-7. PubMed ID: 7968098
    [No Abstract]   [Full Text] [Related]  

  • 17. Nasty or nice? A perspective on the use of health technology assessment in the United Kingdom.
    Drummond M; Sorenson C
    Value Health; 2009 Jun; 12 Suppl 2():S8-13. PubMed ID: 19523188
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing medical technology: lessons for the United States from Quebec and France.
    Rosenau PV
    Int J Health Serv; 2000; 30(3):617-39. PubMed ID: 11109185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From guidance to practice: Why NICE is not enough.
    Dent TH; Sadler M
    BMJ; 2002 Apr; 324(7341):842-5. PubMed ID: 11934781
    [No Abstract]   [Full Text] [Related]  

  • 20. Healthcare technology for managers. The future starts here.
    Stocking B
    Health Serv J; 1992 Oct; 102(5322):26-8. PubMed ID: 10122018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.